Onconic Therapeutics passes preliminary Kosdaq IPO review
Onconic Therapeutics, a subsidiary of Jeil Pharmaceutical, has passed the preliminary examination for its listing on the Kosdaq, clearing the way for a potential initial public offering (IPO) later this year. The company recently launched Jaqbo ( …